CMND - Why Clearmind Medicine Stock Is Moving Higher | Benzinga
Clearmind Medicine Inc. (NASDAQ:CMND) shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development.
What Happened: The agreement with Yissum Research Development grants Clearmind Medicine the exclusive right to develop, manufacture and commercialize compounds invented by professors Rami Yaka, Ahmend Masaewa and Avi Priel of the Hebrew University.
These compounds will work to treat post-traumatic stress disorder (PTSD) along with other mental health conditions. Current ...